Akagi et al. reported that positive immunoreaction for PI3K-p110α was detectable in 50.0% (33/66) of ESCC tissues [9], while our data revealed no statistical significance of PI3K-p110α overexpression between ESCC and the adjacent normal tissues. This evidence concerns the gene PIK3CA and esophageal squamous cell carcinoma.